VRDNViridian Therapeutics, Inc.May 8, 2024Q1 2024
Read transcript →Viridian Therapeutics, Inc. (VRDN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$23.81
+2.01%
Mkt Cap $2.53B
VRDNViridian Therapeutics, Inc.May 8, 2024VRDNViridian Therapeutics, Inc.May 13, 2023Q1 2023
Read transcript →VRDNViridian Therapeutics, Inc.Mar 8, 2023Q4 2022
Read transcript →VRDNViridian Therapeutics, Inc.Nov 14, 2022Q3 2022
Read transcript →VRDNViridian Therapeutics, Inc.Aug 15, 2022Q2 2022
Read transcript →VRDNViridian Therapeutics, Inc.May 12, 2022Q1 2022
Read transcript →VRDNViridian Therapeutics, Inc.Mar 10, 2022Q4 2021
Read transcript →VRDNViridian Therapeutics, Inc.Mar 25, 2021Q4 2020
Read transcript →VRDNViridian Therapeutics, Inc.Aug 5, 2020Q2 2020
Read transcript →VRDNViridian Therapeutics, Inc.May 10, 2020Q1 2020
Read transcript →VRDNViridian Therapeutics, Inc.Mar 11, 2020Q4 2019
Read transcript →VRDNViridian Therapeutics, Inc.Nov 8, 2019Q3 2019
Read transcript →VRDNViridian Therapeutics, Inc.Aug 8, 2019Q2 2019
Read transcript →VRDNViridian Therapeutics, Inc.May 10, 2019Q1 2019
Read transcript →VRDNViridian Therapeutics, Inc.Mar 13, 2019Q4 2018
Read transcript →VRDNViridian Therapeutics, Inc.Nov 7, 2018Q3 2018
Read transcript →VRDNViridian Therapeutics, Inc.Aug 7, 2018Q2 2018
Read transcript →VRDNViridian Therapeutics, Inc.May 9, 2018Q1 2018
Read transcript →VRDNViridian Therapeutics, Inc.Mar 14, 2018Q4 2017
Read transcript →VRDNViridian Therapeutics, Inc.Nov 10, 2017Q3 2017
Read transcript →VRDNViridian Therapeutics, Inc.Aug 11, 2017Q2 2017
Read transcript →VRDNViridian Therapeutics, Inc.May 10, 2017Q1 2017
Read transcript →VRDNViridian Therapeutics, Inc.Mar 16, 2016Q4 2015
Read transcript →